• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有精神病性症状的强迫症及对选择性5-羟色胺再摄取抑制剂治疗的反应

Obsessive-compulsive disorder (OCD) with psychotic symptoms and response to treatment with SSRI.

作者信息

Sievers M, Sato T, Möller H-J, Bottlender R

出版信息

Pharmacopsychiatry. 2005 Mar;38(2):104-5. doi: 10.1055/s-2005-837814.

DOI:10.1055/s-2005-837814
PMID:15744638
Abstract

The co-occurrence of obsessive-compulsive and psychotic symptoms in one patient often represents a diagnostic problem. Distinguishing among a schizophrenic disorder with comorbid obsessional symptoms, an OCD with comorbid psychotic symptoms, or an OCD and schizophrenia or any other psychotic disorder is of clinical importance, since the different diagnoses have different therapeutic as well as prognostic implications. In the following case report we describe a patient who suffered from a typical OCD for more than 18 years and then developed clear psychotic symptoms that completely remitted after treatment with citalopram.

摘要

一名患者同时出现强迫症状和精神病性症状往往代表着一个诊断难题。区分伴有共病强迫症状的精神分裂症、伴有共病精神病性症状的强迫症、或强迫症与精神分裂症或任何其他精神病性障碍,具有临床重要性,因为不同的诊断具有不同的治疗及预后意义。在以下病例报告中,我们描述了一名患有典型强迫症超过18年的患者,之后出现了明确的精神病性症状,在使用西酞普兰治疗后完全缓解。

相似文献

1
Obsessive-compulsive disorder (OCD) with psychotic symptoms and response to treatment with SSRI.伴有精神病性症状的强迫症及对选择性5-羟色胺再摄取抑制剂治疗的反应
Pharmacopsychiatry. 2005 Mar;38(2):104-5. doi: 10.1055/s-2005-837814.
2
Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study.依地普仑治疗精神分裂症和强迫症患者的开放标签前瞻性研究。
Int Clin Psychopharmacol. 2013 Mar;28(2):96-8. doi: 10.1097/YIC.0b013e32835bd24e.
3
[Obsessive-compulsive disorder and schizophrenia. A critical review].[强迫症与精神分裂症。批判性综述]
Fortschr Neurol Psychiatr. 2006 Jan;74(1):32-48. doi: 10.1055/s-2004-830284.
4
Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia.有强迫症与无强迫症的精神分裂症患者的临床特征及共病情况比较:精神分裂症中的精神分裂症症状与强迫症状
J Clin Psychiatry. 2003 Nov;64(11):1300-7. doi: 10.4088/jcp.v64n1104.
5
Citalopram in refractory obsessive-compulsive disorder: an open study.西酞普兰治疗难治性强迫症:一项开放性研究。
Int Clin Psychopharmacol. 2001 Jul;16(4):215-9. doi: 10.1097/00004850-200107000-00005.
6
Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.西酞普兰静脉输注治疗难治性强迫症:一项开放性试验。
J Clin Psychiatry. 2002 Sep;63(9):796-801.
7
Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.米氮平增效西酞普兰对无共病抑郁的强迫症患者反应加速作用的一项初步研究。
J Clin Psychiatry. 2004 Oct;65(10):1394-9. doi: 10.4088/jcp.v65n1015.
8
[Clinical efficacy of citalopram in patients with obsessive-compulsive disorder].西酞普兰治疗强迫症患者的临床疗效
Psychiatr Pol. 2002 Nov-Dec;36(6 Suppl):297-301.
9
Use of the selective serotonin reuptake inhibitor citalopram in a possible animal analogue of obsessive-compulsive disorder.在一种可能的强迫症动物类似模型中使用选择性5-羟色胺再摄取抑制剂西酞普兰。
Depress Anxiety. 1998;8(1):39-42. doi: 10.1002/(sici)1520-6394(1998)8:1<39::aid-da8>3.0.co;2-0.
10
Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment.精神分裂症中的强迫症:临床特征与治疗
CNS Drugs. 2004;18(14):989-1010. doi: 10.2165/00023210-200418140-00004.

引用本文的文献

1
Anxiety Disorders and Perceptual Disturbances in Adolescents with 22q11.2 Deletion Syndrome Treated with SSRI: A Case Series.22q11.2缺失综合征青少年使用选择性5-羟色胺再摄取抑制剂(SSRI)治疗后的焦虑症和知觉障碍:病例系列
J Can Acad Child Adolesc Psychiatry. 2011 Nov;20(4):305-10.
2
Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series.从选择性 5-羟色胺再摄取抑制剂转换为阿戈美拉汀治疗难治性强迫症患者:一项 3 个月随访的病例系列研究。
Ann Gen Psychiatry. 2011 Feb 28;10(1):5. doi: 10.1186/1744-859X-10-5.